BCM
RXDX

Bayesian Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bayesian Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,200
Closed -$242K – 1177
2022
Q4 		$242K Buy
+2,200
New +$242K 0.04% 548